Seres Therapeutics Inc [NASDAQ: MCRB] gained 10.18% or 0.09 points to close at $0.91 with a heavy trading volume of 7424875 shares. The daily chart for MCRB points out that the company has recorded -38.99% loss over the past six months. If we look at
Seres Therapeutics Inc [NASDAQ: MCRB] stock went on an upward path that rose over 21.68% on Tuesday, amounting to a one-week price increase of more than 19.48%. Over the last 12 months, MCRB stock dropped by -88.20%. The one-year Seres Therapeutics Inc stock forecast points
Seres Therapeutics Inc [NASDAQ: MCRB] surged by $0.02 during the normal trading session on while it closed the day at $0.64. Seres Therapeutics Inc stock has also loss -10.33% of its value over the past 7 days. However, MCRB stock has declined by -48.28% in
Seres Therapeutics Inc [NASDAQ: MCRB] traded at a low on Tuesday, posting a -3.14 loss after which it closed the day’ session at $0.71. The company report on April 9, 2024 at 7:00 AM that Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase
Seres Therapeutics Inc [NASDAQ: MCRB] stock went on a downward path that fall over -4.88% on Wednesday, amounting to a one-week price decrease of less than -3.51%. The company report on March 28, 2024 at 7:00 AM that Seres Therapeutics Reports Inducement Grants Under Nasdaq
Seres Therapeutics Inc [NASDAQ: MCRB] price surged by 6.34 percent to reach at $0.05. The company report on March 19, 2024 at 7:00 AM that Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4). Seres Therapeutics, Inc. (Nasdaq: MCRB) (“Seres” or the “Company”), a
Seres Therapeutics Inc [NASDAQ: MCRB] traded at a low on Monday, posting a -11.39 loss after which it closed the day’ session at $0.86. The company report on March 5, 2024 at 7:00 AM that Seres Therapeutics Reports Fourth Quarter and Full Year 2023 Financial
Seres Therapeutics Inc [NASDAQ: MCRB] loss -7.02% or -0.08 points to close at $1.06 with a heavy trading volume of 6691650 shares. The company report on March 5, 2024 at 7:00 AM that Seres Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and
Seres Therapeutics Inc [NASDAQ: MCRB] price surged by 6.54 percent to reach at $0.07. The company report on February 27, 2024 at 7:00 AM that Seres Therapeutics to Participate in Cowen 44th Annual Healthcare Conference. Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company,
Seres Therapeutics Inc [NASDAQ: MCRB] jumped around 0.05 points on Thursday, while shares priced at $1.10 at the close of the session, up 4.76%. The company report on January 17, 2024 at 7:00 AM that Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
© 2024, Powered by Smart TechOne
